Atypical Teratoid Rhabdoid Tumor
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Germ-line and somatic mutations of the hSNF5/INI1 gene have been reported in atypical teratoid/rhabdoid tumors (AT/RTs) of the brain, consistent with its role as a tumor suppressor gene.
|
10914721 |
2000 |
Atypical Teratoid Rhabdoid Tumor
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
A mutation or deletion in the INI1 gene occurs in the majority of AT/RT tumors.
|
16195799 |
2005 |
Atypical Teratoid Rhabdoid Tumor
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
AT/RTs are characterized by biallelic inactivating mutations of the gene SMARCB1 in 98% of patients; these mutations may serve as molecular markers for residual tumor cell detection in liquid biopsies.
|
25016934 |
2014 |
Atypical Teratoid Rhabdoid Tumor
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
In a family in which two carrier children had germline SMARCB1 mutations and atypical teratoid rhabdoid tumor, we report malignant progression of a nerve sheath tumor over a 7-year period in an affected adult family member.
|
29512865 |
2018 |
Atypical Teratoid Rhabdoid Tumor
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Recently, germline mutation of the hSNF5/INI1 gene has been reported in association with AT/RTs.
|
15881754 |
2005 |
Atypical Teratoid Rhabdoid Tumor
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
In addition, it did not have homozygous deletion of SMARCB1 gene, but it rather showed a frameshift mutation at exon 4 of SMARCB1 which had not been previously found in ATRT.
|
29110337 |
2018 |
Atypical Teratoid Rhabdoid Tumor
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Inactivating mutations of the hSNF5/INI-1 gene located in the chromosomal region 22q11.2 are regarded as a crucial step in the molecular pathogenesis of ATRTs; the genetic changes associated with CPTs are largely unknown.
|
12946029 |
2003 |
Atypical Teratoid Rhabdoid Tumor
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Atypical teratoid/rhabdoid tumor (AT/RT) is a rhabdoid tumor of the central nervous system comprising a mixture of small round cells and mesenchymal and/or epithelial elements, showing mutation of the SMARCB1 gene or SMARCA4 gene.
|
23880166 |
2013 |
Atypical Teratoid Rhabdoid Tumor
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Atypical teratoid/rhabdoid tumor (AT/RT) is a malignant tumor that is commonly associated with biallelic alterations of SMARCB1.
|
28731921 |
2017 |
Atypical Teratoid Rhabdoid Tumor
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Here we report on an infant diagnosed with Goldenhar syndrome (GS) phenotype who developed an atypical teratoid rhabdoid tumor (AT/RT) of the brain due to a distal deletion of the chromosome 22q11.2 region encompassing the INI1/SMARCB1 tumor suppressor.
|
19938088 |
2009 |
Atypical Teratoid Rhabdoid Tumor
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Since MRTK and atypical teratoid rhabdoid tumor (ATRT) of the brain share a common mutation in the gene (hSNF5/INI1), hence a diagnosis of MRTK with co-existent ATRT of the brain was established.
|
31632875 |
2019 |
Atypical Teratoid Rhabdoid Tumor
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
A consistent fraction of cases carries de-novo SMARCB1/INI1 constitutional mutations in the setting of the "rhabdoid tumor predisposition syndrome" and the outcome is worst in infant syndromic ATRT patients.
|
23510391 |
2013 |
Atypical Teratoid Rhabdoid Tumor
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
The finding of an INI1 alteration in an atypical teratoid/rhabdoid tumor or malignant neoplasm with overlapping histologic features will be required for entry onto disease-specific protocols within the Children's Oncology Group.
|
15485613 |
2004 |
Atypical Teratoid Rhabdoid Tumor
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Abnormalities of SMARCB1 (INI1), which encodes a member of the SWI/SNF pathway, are found in neoplasms with rhabdoid morphology, such as malignant rhabdoid tumour of the kidney and atypical teratoid/rhabdoid tumour of the central nervous system.
|
27656868 |
2017 |
Atypical Teratoid Rhabdoid Tumor
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
These results suggest that alterations of the hSNF5/INI1 gene were restricted to MRTs or AT/RTs in pediatric solid tumors.
|
11921280 |
2002 |
Atypical Teratoid Rhabdoid Tumor
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Predisposition to atypical teratoid/rhabdoid tumor due to an inherited INI1 mutation.
|
16261613 |
2006 |
Atypical Teratoid Rhabdoid Tumor
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Molecular genetic analysis of AT/RT demonstrates deletion and mutation of the hSNF5/INI1 gene in most cases, with decreased or absent expression at the RNA or protein level.
|
15105654 |
2004 |
Atypical Teratoid Rhabdoid Tumor
|
0.800 |
Biomarker
|
disease |
BEFREE |
This unique case supports the notion that routine application of INI1 stains/in situ hybridization can capture AT/RT with unexpected patterns of differentiation.
|
24034858 |
2014 |
Atypical Teratoid Rhabdoid Tumor
|
0.800 |
Biomarker
|
disease |
BEFREE |
We present here a rare case of an adult (35 years) low-grade SMARCB1-deleted brain tumor with transition into prototypical AT/RT over 14 years.
|
28789476 |
2017 |
Atypical Teratoid Rhabdoid Tumor
|
0.800 |
Biomarker
|
disease |
BEFREE |
The low overlap of dysregulated genes in AT/RTs and KRTs suggests that factors in addition to SMARCB1 loss play a role in determining subsequent gene expression.
|
23382118 |
2013 |
Atypical Teratoid Rhabdoid Tumor
|
0.800 |
Biomarker
|
disease |
CLINGEN |
Immunohistochemical analysis of hSNF5/INI1 in pediatric CNS neoplasms.
|
15105654 |
2004 |
Atypical Teratoid Rhabdoid Tumor
|
0.800 |
Biomarker
|
disease |
BEFREE |
In conclusion, these data further suggest the absence of recurrent genomic alterations other than SMARCB1 in AT/RT.
|
23074045 |
2013 |
Atypical Teratoid Rhabdoid Tumor
|
0.800 |
Biomarker
|
disease |
MGD |
Tumor-specific cooperation of retinoblastoma protein family and Snf5 inactivation.
|
17409406 |
2007 |
Atypical Teratoid Rhabdoid Tumor
|
0.800 |
Biomarker
|
disease |
BEFREE |
The prototypical SMARCB1-deficient tumor is the malignant rhabdoid tumor (MRT) which was first described in the kidney but also occurs in soft tissue, viscera, and the brain (where it is referred to as atypical teratoid rhabdoid tumor or AT/RT).
|
29280680 |
2019 |
Atypical Teratoid Rhabdoid Tumor
|
0.800 |
Biomarker
|
disease |
MGD |
Genetic ablation of Cyclin D1 abrogates genesis of rhabdoid tumors resulting from Ini1 loss.
|
16099835 |
2005 |